Figures & data
Table I. Proposals to improve clinical understanding and impact of a preclinical study.
Table II. Table II gives the minimum requirements for any proof of concept or preclinical study and the additional requirements specific to preclinical studies. We suggest this table be used as a check list for both investigators and reviewers.
Table III. Recommendations for the use of animals.
Table IV. Recommendations for pharmacological and toxicological studies in a preclinical drug testing study. We recommend that most of the information will be obtained by industrial partners.
Table V. Summary of new technologies providing a high likelihood of fulfilling these needs.